Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis Hospitalized for a pulmonary exacerbation

European Journal of Clinical Nutrition

Volumn 66, Issue 9, 2012, Pages 1072-1074

  Grossmann, R E ^a   Zughaier, S M ^b,c   Liu, S ^d   Lyles, R H ^d   Tangpricha, V ^a,b,c,e  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Center for Cystic Fibrosis Research   (United States)

^d EMORY UNIVERSITY   (United States)

^e ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

cystic fibrosis; inflammation; interleukin 6; tumor necrosis factor ; vitamin D

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLECALCIFEROL; INTERLEUKIN 10; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; HUMAN; LUNG DISEASE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ACUTE-PHASE PROTEINS; ADULT; CATHELICIDINS; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; INTERLEUKINS; LINEAR MODELS; LIPOCALINS; MALE; PROTO-ONCOGENE PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D;

EID: 84865988668     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.82     Document Type: Article

References (10)

1. Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest 2008; 133: 489-495. (Pubitemid 351272410)
2. Jacquot J, Tabary O, Le Rouzic P, Clement A. Airway epithelial cell inflammatory signalling in cystic fibrosis. Int J Biochem Cell Biol 2008; 40: 1703-1715.
3. Hall WB, Sparks AA, Aris RM. Vitamin D deficiency in cystic fibrosis. Int J Endocrinol 2010; 2010: 218691.
4. McNally P, Coughlan C, Bergsson G, Doyle M, Taggart C, Adorini L et al. Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. J Cyst Fibros 2011; 10: 428-434.
5. Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol 2010; 21: 353-361.
6. Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25- dihydroxyvitamin D-3. J Cyst Fibros 2007; 6: 403-410. (Pubitemid 350028703)
7. Grossmann RE, Tangpricha V, Zughaier SM, Liu S. Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: a randomized, controlled trial. Dermato-Endocrinology 2012; 4: 1-8.
8. Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012; 188: 2127-2135.
9. Khazai NB, Judd SE, Jeng L, Wolfenden LL, Stecenko A, Ziegler TR et al. Treatment and Prevention of Vitamin D Insufficiency in Cystic Fibrosis Patients: Comparative Efficacy of Ergocalciferol, Cholecalciferol, and UV Light. J Clin Endocrinol Metab 2009; 94: 2037-2043.
10. Pincikova T, Nilsson K, Moen IE, Karpati F, Fluge G, Hollsing A et al. Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study. Eur J Clin Nutr 2011; 65: 102-109.